by Mooslet Writing Services | Jun 9, 2016 | Big Pharma Business
There’s a new face in the crowded pharmaceutical marketplace – Samsung. The mobile technology juggernaut responsible for Galaxy smartphones is diversifying into the lucrative biosimilar pharmaceutical business. Samsung already makes medical devices like...
by Mooslet Writing Services | Jun 6, 2016 | Big Pharma Business
In a presentation to investors last month, Eli Lilly revealed its ambitious plan to launch 20 new drugs over the next seven years. The Indianapolis-based pharmaceutical behemoth also declared its intention to add more uses to its existing therapies – all by the...
by Mooslet Writing Services | Jun 1, 2016 | Big Pharma Business
Amid bad press for rising prescription drug costs, drug companies have discovered a new revenue stream that comes from an unlikely place: charity donations. Yes, drug companies can make more money by donating to charity – here’s how it works. Step 1: Pharma...
by Mooslet Writing Services | May 24, 2016 | Big Pharma Business
In the wake of two big legal losses for Johnson & Johnson (J&J), the company that has been accused of covering up evidence that its talc products cause cancer is now throwing the better part of a billion dollars into cancer research. How’s that for irony?...
by Mooslet Writing Services | Apr 14, 2016 | Big Pharma Business
Pfizer refused to put a ring on it – on Allergan, that is. That’s right: the Pfizer and Allergan merger is off. The two large pharmaceutical companies had been planning a $150 billion wedding, to be celebrated by a honeymoon in Ireland, Allergan’s home turf. The...
by Mooslet Writing Services | Apr 6, 2016 | Big Pharma Business
Pharmaceutical companies are often at odds with the Food & Drug Administration (FDA). It’s become common practice for big pharma to buck compliance with FDA guidelines and then fork over some cash to pay penalty fines. Are pharmaceutical companies really trying to...
Recent Comments